Dow Pharmaceutical Sciences Becomes Wholly Owned Subsidiary as Acquisition by Valeant Pharmaceuticals International is Completed

PETALUMA, Calif.--(BUSINESS WIRE)--Dow Pharmaceutical Sciences, the leading provider of topical formulation development services for prescription pharmaceutical products, announced that, effective December 31, 2008, the acquisition of Dow Pharmaceutical Sciences by Valeant Pharmaceuticals International has been completed. The Company will operate as a wholly owned subsidiary of Valeant and will continue to provide world-class topical product development services for current and new clients.